BRIC Over The Counter (OTC) Pharmaceuticals Industry Guide 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "OTC Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2016" report to their offering.

The BRIC OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the otc pharmaceuticals industry and had a total market value of $29,244.5 million in 2015. India was the fastest growing country with a CAGR of 9.7% over the 2011-15 period.

Within the otc pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $19,005.3 million in 2015. This was followed by Brazil, Russia and India with a value of $4,381.0, $3,795.5, and $2,062.7 million, respectively.

China is expected to lead the otc pharmaceuticals industry in the BRIC nations with a value of $25,516.5 million in 2020, followed by Brazil, Russia, India with expected values of $6,200.1, $4,597.8 and $3,252.5 million, respectively.

Key Topics Covered:

  1. Introduction
  2. BRIC OTC Pharmaceuticals Industry Outlook
  3. OTC Pharmaceuticals in Brazil
  4. OTC Pharmaceuticals in China
  5. OTC Pharmaceuticals in India
  6. OTC Pharmaceuticals in Russia
  7. Macroeconomic indicators
  8. Company Profiles
  9. Leading companies
  • Abbott Laboratories
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Sanofi SA
  • Huangshan Tianmu Pharmaceutical Co., Ltd.
  • Nin Jiom Medicines Manufactory Ltd
  • Cipla Limited
  • Dabur India Limited
  • JSC ELFA
  • The Menarini Group
  • Pharmstandard OJSC
  • Abbott Laboratories
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Sanofi SA
  • Cipla Limited
  • Dabur India Limited
  • Pharmstandard OJSC

For more information about this report visit http://www.researchandmarkets.com/research/7dj3b3/otc

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs